By Tony O’Reilly-
A significant economic boost is heading to the Scottish Borders as Breathe Life Sciences, an international medicinal cannabis manufacturer, plans to establish a new production and distribution facility in the region that could ultimately provide around 100 jobs over the next three years.
The announcement has been welcomed by local government and business leaders who see the investment as a sign of confidence in Scotland’s life sciences sector while also creating skilled employment in a rural area.
AD: Capeesh Restaurant
The Australia-based company, founded in 2018, has secured nearly £850,000 in funding from South of Scotland Enterprise (SOSE) to build and operate the centre. Officials said the site, located in a currently undisclosed location in the Scottish Borders, will be used to manufacture and supply medicinal cannabis products to patients across the UK.
Initially the facility is expected to create about 36 jobs, with long-term plans to increase staffing levels to 100 or potentially more as operations scale up.
Breathe Life Sciences is not the first cannabis-related investment to catch Scotland’s attention in recent years. Developments in both cultivation and processing have surfaced across the country, including ventures in Dumfries and Galloway and other regions that aim to strengthen domestic production of medicines previously imported from overseas.
AD: Oysterian Sea Food Restaurant And Bar
Medicinal cannabis has been legal in the UK since legislative changes in 2018, allowing specially licensed doctors to prescribe cannabis-based medicines for conditions such as chronic pain, epilepsy, and post-traumatic stress disorder when other treatments have failed.
That legalisation opened the door for commercial operators to meet growing demand in a market that continues to expand.
Strategic Investment for the Scottish Borders Economy
Supporters of the project argue the investment represents not only job creation but also long-term economic potential for a region often seeking new industries and opportunities. Scottish Borders Council and SOSE described the deal as an important milestone for the area’s reputation in life sciences and innovation.
Russel Griggs, chair of SOSE, said the enterprise could help establish the South of Scotland as a hub for cutting-edge science while bringing skilled jobs and new economic activity to local communities.
The nature of the work at the new facility means roles will vary widely. Workers are expected to be needed across manufacturing, laboratory quality assurance, automated production lines, and administrative functions tied to pharmaceutical production standards.
Construction of specialized infrastructure including clean rooms and controlled drugs storage areas will also support the early phases of job growth and is anticipated to take several months.
Unlike some medicinal cannabis projects that focus on cultivation, Breathe Life Sciences’ Borders operation will concentrate on processing and packaging finished products for patient use, drawing raw materials from various licensors and suppliers before turning them into prescribed medicines.
This approach reflects a growing trend in the industry where processing and quality control are seen as strategic strengths in bringing products to market efficiently.
The announcement arrives amid broader activity in Scotland’s life sciences sector, which has drawn investment and expansion in recent years. Major companies have made significant commitments to research and manufacturing, and clusters of biotechnology, pharmaceutical and advanced drug production facilities have emerged in various regions of the country.
Scotland’s established higher education and research institutions contribute to that ecosystem by fostering skilled graduates and collaborative opportunities with industry.
Local political leaders have also highlighted the importance of national policy in encouraging such investments. Scotland’s devolved government, along with UK trade and industry initiatives, has pursued strategies to lure international companies and support high-value job creation.
Observers see the Borders deal as part of a larger picture in which life sciences are central to economic diversification efforts.
Rising Demand and Market Dynamics
The market for medicinal cannabis products is growing rapidly both within the UK and globally. Industry data suggests a sharp increase in patients using prescribed cannabis-based treatments, with expectations that the number of users could double in the next few years.
Analysts point to expanded awareness of therapeutic benefits and a slow but rising acceptance among healthcare providers as key drivers of increased demand.
Breathe Life Sciences’ entry into the UK landscape adds momentum to this trend. In Australia and other countries where the company already operates, it has produced a range of cannabis-derived medications and investigational compounds.
Its strategy in the Scottish Borders reflects confidence in the UK’s regulatory environment and the potential for high-quality manufacturing to serve a growing patient base.
Critics of the medicinal cannabis industry, however, caution that regulatory complexity and ongoing debates about medical efficacy could present challenges.
While prescriptions are legally permissible, the number of doctors prepared to prescribe cannabis remains relatively low compared with other treatments, and there are calls for more clinical research and clearer guidelines to support broader medical adoption. Despite these hurdles, investor interest remains high because of projected market expansion and unmet medical needs.
In Scotland, where specialist clinics have opened in urban centres such as Stirling and Dundee to serve patients, the availability of domestically manufactured products could reduce reliance on imports and potentially lower costs for patients and healthcare systems.
Observers note that access issues sometimes push patients to private clinics or out-of-pocket expenses, and increased domestic production may help improve accessibility.
Government and industry advocates alike emphasise that clear regulation, quality control and robust supply chains are central to building a sustainable medicinal cannabis sector. Licensing regimes and state oversight aim to ensure product safety and consistency, which are crucial for public trust and medical acceptance.
The Scottish Borders project will operate under strict controls consistent with UK standards for controlled drugs and pharmaceutical manufacturing.
Manufacturing innovation also plays a role. Breathe Life Sciences intends to invest in advanced production lines and laboratory infrastructure that meet high international standards, helping ensure Scotland remains competitive within the European and global markets.
These investments align with broader efforts to position the UK as a centre of excellence in medicines manufacturing, particularly in areas tied to patient-specific therapies and rapid production response.
The new facility is expected to start operations towards the end of the next year, subject to licensing and completion of required upgrades. In the meantime, recruitment efforts and preparatory work will begin, giving local residents and jobseekers early opportunities to engage with training and employment pathways tied to the project.
Stakeholders believe the effects of the expansion will ripple beyond the Borders, influencing supply chains, creating ancillary services and reinforcing Scotland’s profile as a destination for sophisticated health-science investments.
Community leaders hope that the combination of government support, private investment and a receptive workforce will turn this initiative into a long-term success story, with benefits for patients, employees and the broader economy.
In a landscape where life sciences and innovative health products are becoming increasingly central to economic and social planning, the creation of around 100 jobs through this medicinal cannabis expansion signals not just a business decision but also a shift in how rural regions can tap into high-value sectors and global markets.
AD: Heritage And Restaurant Lounge Bar